Ultragenyx Pharmaceutical Inc

RARE

Add to Watchlist

32.870USD

-0.520-1.56%

Market hours （ET）Quotes delayed by 15 min

3.23BMarket Cap

LossP/E TTM

Ultragenyx Pharmaceutical Inc

32.870

-0.520-1.56%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Ultragenyx Pharmaceutical Inc's Company Valuation

Currency: USD Updated: 2026-06-30

Previous score

9.17

Change

The current valuation score of Ultragenyx Pharmaceutical Inc is 9.17, ranking 40 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -5.47, which is -42.03% below the recent high of -3.17 and -66.16% above the recent low of -9.09.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.